The DOI matches its Crossref record; 33 of the 35 references it cites were found in a registry or an index.
First infection by all four non-severe acute respiratory syndrome human coronaviruses takes place during childhood
Open accessAbstract
Background: Non-severe acute respiratory syndrome (non-SARS)-related human coronaviruses (HCoVs), including HCoV-229E, -HKU1, -NL63, and -OC43, have been detected in respiratory tract samples from children and adults. However, the natural prevalence of antibodies against these viruses in serum among population is unknown. Methods: To measure antibodies to the spike (S) protein of the four common non-SARS HCoVs, recombinant S proteins of the four HCoVs were expressed and characterised in 293 T cell. An S-protein-based indirect immunofluorescence assay (IFA) was then developed to detect anti-S IgG and IgM for the four individual HCoVs and applied to serum samples from a general asymptomatic population (218 children and 576 adults) in Beijing. Results: Of 794 blood samples tested, only 29 (3.65%) were negative for anti-S IgG. The seropositivity of the four anti-S IgG antibodies was >70% within the general population. The majority of seroconversions to four-HCoV positivity first occurred in children. Both S-IgG and S-IgM antibodies were detectable among children and increased with age, reaching a plateau at 6 years of age. However, no anti-S IgM was detected in healthy adults. Conclusion: Large proportions of children and adults in Beijing have evidence of anti-S IgG against four the HCoVs, and first infections by all four non-SARS HCoVs takes place during childhood.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Endemic hCoVs circulate worldwide and cause widespread infection during childhood73.”
From Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection (2021) · cites this paper as [73]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Woo, P. C. Y., Lau, S. K. P., Wong, B. H. L., Chan, K., Hui, W.-T., Kwan, G., Peiris, M. J. S., Couch, R. B., & Yuen, K. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.12.5885-5888.2004 · Cited by 86
RetractedChan, C.-M., Woo, P. C. Y., Lau, S. K. P., Tse, H., Chen, H., Li, F., Zheng, B.-J., Chen, L., Huang, J., & Yuen, K. (2008) · Experimental Biology and Medicine · doi:10.3181/0806-rm-197 · Cited by 41
RetractedIdentification of a novel coronavirus in patients with severe acute respiratory syndrome
Drosten, C., Günther, S., Preiser, W., van der Werf, S., Brodt, H.-R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030747 · Cited by 4,574
A Novel Coronavirus Associated with Severe Acute Respiratory Syndrome
Tg, K., Erdman, D. D., Cs, G., Zaki, Peret, T. C. T., Emery, S. L., Tong, S., Urbani, C., Comer, J. A., Lim, W., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030781 · Cited by 4,353
Identification of a new human coronavirus
van der Hoek, L., Pyrć, K., Jebbink, M. F., Vermeulen-Oost, W., Berkhout, R. J. M., Wolthers, K. C., Dillen, P. M. E. W., Kaandorp, J. C., Spaargaren, J., & Berkhout, B. (2004) · Nature Medicine · doi:10.1038/nm1024 · Cited by 1,868
Woo, P. C. Y., Lau, S. K. P., Chu, C., Chan, K., Tsoi, H., Huang, Y. P., Wong, B. H. L., Poon, R. W., Cai, J. J., Luk, W., et al. (2004) · Journal of Virology · doi:10.1128/jvi.79.2.884-895.2005 · Cited by 1,525
A New Virus Isolated from the Human Respiratory Tract.
Hamre, D. M., & Procknow, J. J. (1966) · Experimental Biology and Medicine · doi:10.3181/00379727-121-30734 · Cited by 888
Hofmann, H., Pyrc, K., van der Hoek, L., Geier, M., Berkhout, B., & Pöhlmann, S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409465102 · Cited by 824
Coronavirus Genome Structure and Replication
Brian, D. A., & Baric, R. S. (2005) · Current topics in microbiology and immunology · doi:10.1007/3-540-26765-4_1 · Cited by 758
Gaunt, E. R., Hardie, A., Claas, E. C. J., Peter Simmonds, K., & Templeton, K. E. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.00636-10 · Cited by 699
Research works printed but not linked: 1
- Lai MMC, Perlman S, Anderson LJ: Coronaviridae. Fields virology. Edited by: Fields BN, Knipe DM, Howley PM. 2007, Philadelphia: Lippincott Williams & Wilkins Press, 1305-1335. 5
Cited by
Sorted by citations
Huang, A. T., Garcia-Carreras, B., Hitchings, M. D. T., Yang, B., Katzelnick, L. C., Rattigan, S. M., Borgert, B. A., Moreno, C. A., Solomon, B. D., Trimmer-Smith, L., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18450-4 · Cited by 1,026
Seasonal coronavirus protective immunity is short-lasting
Edridge, A. W. D., Kaczorowska, J., Hoste, A. C. R., Bakker, M., Klein, M., Loens, K., Jebbink, M. F., Matser, A., Kinsella, C. M., Rueda, P., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1083-1 · Cited by 767
Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19
Juno, J. A., Tan, H.-X., Lee, W. S., Reynaldi, A., Kelly, H. G., Wragg, K., Esterbauer, R., Kent, H. E., Batten, C. J., Mordant, F. L., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0995-0 · Cited by 437
Immunological characteristics govern the transition of COVID-19 to endemicity
Lavine, J. S., Bjornstad, O. N., & Antia, R. (2021) · Science · doi:10.1126/science.abe6522 · Cited by 416
Proteolytic processing of Middle East respiratory syndrome coronavirus spikes expands virus tropism
Park, J.-E., Li, K., Barlan, A., Fehr, A. R., Perlman, S. M., McCray, P. B., & Gallagher, T. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1608147113 · Cited by 306
Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection
Cromer, D., Juno, J. A., Khoury, D., Reynaldi, A., Wheatley, A. K., Kent, S. J., & Davenport, M. P. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00550-x · Cited by 265
de Assis, R. R., Jain, A., Nakajima, R., Jasinskas, A., Felgner, J. H., Obiero, J. M., Norris, P. J., Stone, M., Simmons, G., Bagri, A., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20095-2 · Cited by 201
Wang, F., Chen, C., Tan, W., Yang, K., & Yang, H. (2016) · Scientific Reports · doi:10.1038/srep22677 · Cited by 185
Self-citationIdentification of New Respiratory Viruses in the New Millennium
Berry, M. J., Gamieldien, J., & Fielding, B. C. (2015) · Viruses · doi:10.3390/v7030996 · Cited by 163
Molecular Basis of Coronavirus Virulence and Vaccine Development
Enjuanes, L., Zúñiga, S., Castaño-Rodríguez, C., Gutierrez-Alvarez, F. J., Cantón, J., & Sola, I. (2016) · Advances in virus research · doi:10.1016/bs.aivir.2016.08.003 · Cited by 165
Direct Observation of Repeated Infections With Endemic Coronaviruses
Galanti, M., & Shaman, J. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa392 · Cited by 149
Carbajo-Lozoya, J., Ma‐Lauer, Y., Malešević, M., Theuerkorn, M., Kahlert, V., Prell, E., von Brunn, B., Muth, D., Baumert, T. F., Drosten, C., et al. (2014) · Virus Research · doi:10.1016/j.virusres.2014.02.010 · Cited by 140
Convalescent Plasma Therapy for COVID-19: State of the Art
Focosi, D., Anderson, A. O., Tang, J. W.-T., & Tuccori, M. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00072-20 · Cited by 125
Ogbe, A., Kronsteiner, B., Skelly, D., Pace, M. J., Brown, A., Adland, E., Adair, K., Akhter, H. D., Ali, M., Ali, S.-E., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21856-3 · Cited by 124
Khan, S., Nakajima, R., Jain, A., de Assis, R. R., Jasinskas, A., Obiero, J. M., Adenaiye, O., Tai, S., Hong, F. H., Milton, D. K., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.24.006544 · Cited by 118
Zheng, Y., Li, R., & Liu, S. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26009 · Cited by 105
Impact of antigenic evolution and original antigenic sin on SARS-CoV-2 immunity
Aguilar-Bretones, M., Fouchier, R. A. M., Koopmans, M., & van Nierop, G. P. (2023) · Journal of Clinical Investigation · doi:10.1172/jci162192 · Cited by 108
Immunologic Testing for SARS-CoV-2 Infection from the Antigen Perspective
Li, D., & Li, J. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.02160-20 · Cited by 94
SARS-CoV-2 antibody testing—questions to be asked
Özcürümez, M. K., Ambrosch, A., Frey, O., Haselmann, V., Holdenrieder, S., Kiehntopf, M., Neumaier, M., Walter, M., Wenzel, F., Wölfel, R., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.05.020 · Cited by 83
Robust and durable serological response following pediatric SARS-CoV-2 infection
Renk, H., Dulovic, A., Seidel, A., Becker, M., Fabricius, D., Zernickel, M., Junker, D., Groß, R. M., Müller, J. A., Hilger, A., et al. (2022) · Nature Communications · doi:10.1038/s41467-021-27595-9 · Cited by 81
Functional SARS-CoV-2 cross-reactive CD4 + T cells established in early childhood decline with age
Humbert, M., Olofsson, A., Wullimann, D., Niessl, J., Hodcroft, E. B., Cai, C., Gao, Y., Sohlberg, E., Dyrdak, R., Mikaeloff, F., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2220320120 · Cited by 76
Berry, M. J., Fielding, B. C., & Gamieldien, J. (2015) · Viruses · doi:10.3390/v7122963 · Cited by 68
Sermet‐Gaudelus, I., Temmam, S., Huon, C., Behillil, S., Gajdos, V., Bigot, T., Lurier, T., Chrétien, D., Backović, M., Delaunay, A., et al. (2021) · Eurosurveillance · doi:10.2807/1560-7917.es.2021.26.13.2001782 · Cited by 70
Immunoreactive peptide maps of SARS-CoV-2
Mishra, N., Huang, X., Joshi, S., Guo, C., Ng, J., Thakkar, R., Wu, Y., Dong, X., Li, Q., Pinapati, R. S., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-01743-9 · Cited by 65
Waning antibody responses in COVID-19: what can we learn from the analysis of other coronaviruses?
Hamady, A., Lee, J., & Loboda, Z. (2021) · Infection · doi:10.1007/s15010-021-01664-z · Cited by 66
Woudenberg, T., Pelleau, S., Anna, F., Attia, M., Donnadieu, F., Gravet, A., Lohmann, C., Séraphin, H., Guihéneuf, R., Delamare, C., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103495 · Cited by 64
Is Cross-Reactive Immunity Triggering COVID-19 Immunopathogenesis?
Beretta, A., Cranage, M. P., & Zipeto, D. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.567710 · Cited by 56
A majority of uninfected adults show preexisting antibody reactivity against SARS-CoV-2
Majdoubi, A., Michalski, C., O’Connell, S. E., Dada, S., Narpala, S., Gelinas, J. P., Mehta, D., Cheung, C., Winkler, D. F. H., Basappa, M., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.146316 · Cited by 57
Durability of Immunity to SARS-CoV-2 and Other Respiratory Viruses
Siggins, M. K., Thwaites, R. S., & Openshaw, P. (2021) · Trends in Microbiology · doi:10.1016/j.tim.2021.03.016 · Cited by 61
Nanomaterial-based drug delivery systems as promising carriers for patients with COVID-19
Elkodous, M. A., Olojede, S. O., Morsi, M., & El-Sayyad, G. S. (2021) · RSC Advances · doi:10.1039/d1ra04835j · Cited by 55
Role of the humoral immune response during COVID-19: guilty or not guilty?
Yaugel-Novoa, M., Bourlet, T., & Paul, S. (2022) · Mucosal Immunology · doi:10.1038/s41385-022-00569-w · Cited by 57
Qian, Z., Ou, X., Góes, L. G. B., Osborne, C. M., Castano, A. M., Holmes, K. V., & Dominguez, S. R. (2015) · Journal of Virology · doi:10.1128/jvi.03737-14 · Cited by 52
Soleimani, R., Khourssaji, M., Gruson, D., Rodriguez‐Villalobos, H., Berghmans, M., Belkhir, L., Yombi, J. C., & Kabamba‐Mukadi, B. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26430 · Cited by 52
Wang, C., Hesketh, E. L., Shamorkina, T. M., Li, W., Franken, P. J., Drabek, D., van Haperen, R., Townend, S., van Kuppeveld, F. J. M., Grosveld, F. G., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30658-0 · Cited by 52
COVID ‐19 and plasma cells: Is there long‐lived protection?*
Nguyen, D. C., Lamothe, P. A., Woodruff, M. C., Saini, A. S., Faliti, C. E., Sanz, I., & Lee, F. E.-H. (2022) · Immunological Reviews · doi:10.1111/imr.13115 · Cited by 48
Cohen, L., Spiro, D. J., & Viboud, C. G. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010591 · Cited by 42
Tamminen, K., Salminen, M., & Blazevic, V. (2021) · Clinical Immunology · doi:10.1016/j.clim.2021.108782 · Cited by 39
Dyrdak, R., Hodcroft, E. B., Wahlund, M., Neher, R. A., & Albert, J. (2021) · Journal of Clinical Virology · doi:10.1016/j.jcv.2021.104754 · Cited by 34
Jacob-Dolan, C., Feldman, J. E., McMahan, K., Yu, J., Zahn, R. C., Wegmann, F., Schuitemaker, H., Schmidt, A. G., & Barouch, D. H. (2021) · Journal of Virology · doi:10.1128/jvi.00117-21 · Cited by 32
Ulytė, A., Radtke, T., Abela, I. A., Haile, S. R., Blankenberger, J., Jung, R., Capelli, C., Berger, C., Frei, A. L., Huber, M., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-047483 · Cited by 32
Alves, D., Curvello, R., Henderson, E. C., Kesarwani, V., Walker, J. A., Leguizamon, S., McLiesh, H., Raghuwanshi, V. S., Samadian, H., Wood, E. M., et al. (2020) · ACS Sensors · doi:10.1021/acssensors.0c01050 · Cited by 30
Kallikrein 13 serves as a priming protease during infection by the human coronavirus HKU1
Milewska, A., Falkowski, K., Kulczycka, M., Bielecka, E., Naskalska, A., Mak, P., Lesner, A., Ochman, M., Urlik, M., Diamandis, E. P., et al. (2020) · Science Signaling · doi:10.1126/scisignal.aba9902 · Cited by 30
Age, Disease Severity and Ethnicity Influence Humoral Responses in a Multi-Ethnic COVID-19 Cohort
Smith, M., Abdesselem, H., Mullins, M. O., Tan, T.-M., Nel, A. J. M., Al‐Nesf, M. A., Bensmail, I., Majbour, N. K., Vaikath, N. N., Naik, A., et al. (2021) · Viruses · doi:10.3390/v13050786 · Cited by 27
Lehmann, A. A., Kirchenbaum, G. A., Zhang, T., Reche, P. A., & Lehmann, P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.635942 · Cited by 27
Wang, J., & Zand, M. S. (2020) · Journal of Clinical and Translational Science · doi:10.1017/cts.2020.39 · Cited by 26
Repertoires of SARS-CoV-2 epitopes targeted by antibodies vary according to severity of COVID-19
Gregory, D. J., Vannier, A., Duey, A. H., Roady, T. J., Dzeng, R. K., Pavlovic, M., Chapin, M. H., Mukherjee, S., Wilmot, H., Chronos, N., et al. (2022) · Virulence · doi:10.1080/21505594.2022.2073025 · Cited by 23
Immunological imprinting of humoral immunity to SARS-CoV-2 in children
Dowell, A. C., Lancaster, T., Bruton, R. K., Ireland, G., Bentley, C., Sylla, P., Zuo, J., Scott, S., Jadir, A., Begum, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39575-2 · Cited by 25
Dijkstra, J. M., & Hashimoto, K. (2020) · F1000Research · doi:10.12688/f1000research.23458.1 · Cited by 20
Evolutionary medical insights into the SARS-CoV-2 pandemic
Crespi, B. J. (2020) · Evolution Medicine and Public Health · doi:10.1093/emph/eoaa036 · Cited by 20
Thomas, S. N., Altawallbeh, G., Zaun, C. P., Pape, K. A., Peters, J. M., Titcombe, P. J., Dileepan, T., Rapp, M. J., Bold, T. D., Schacker, T. W., et al. (2020) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2021.01.010 · Cited by 20
Pinotti, F., Wikramaratna, P. S., Obolski, U., Paton, R. S., Damineli, D. S. C., Alcântara, L. C. J., Giovanetti, M., Gupta, S., & Lourenço, J. (2021) · BMC Medicine · doi:10.1186/s12916-020-01887-1 · Cited by 19
Sayama, Y., Okamoto, M., Saito, M., Saito‐Obata, M., Tamaki, R., Joboco, C. D., Lupisan, S., & Oshitani, H. (2023) · Scientific Reports · doi:10.1038/s41598-023-29072-3 · Cited by 21
Mahalingam, S., Peter, J., Xu, Z., Bordoloi, D., Ho, M., Kalyanaraman, V. S., Srinivasan, A., & Muthumani, K. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e06836 · Cited by 20
Single-Dilution COVID-19 Antibody Test with Qualitative and Quantitative Readouts
Bortz, R. H., Florez, C., Laudermilch, E., Wirchnianski, A. S., Lasso, G., Malonis, R. J., Georgiev, G. I., Vergnolle, O., Herrera, N. G., Morano, N. C., et al. (2021) · mSphere · doi:10.1128/msphere.00224-21 · Cited by 20
Adaptive immunity to human coronaviruses is widespread but low in magnitude
Tan, H., Lee, W. S., Wragg, K. M., Nelson, C., Esterbauer, R., Kelly, H. G., Amarasena, T. H., Jones, R. M., Starkey, G., Wang, B. Z., et al. (2021) · Clinical & Translational Immunology · doi:10.1002/cti2.1264 · Cited by 18
Five reasons COVID-19 is less severe in younger age-groups
Turke, P. W. (2020) · Evolution Medicine and Public Health · doi:10.1093/emph/eoaa050 · Cited by 20
Tanunliong, G., Liu, A. C., Kaweski, S. E., Irvine, M. A., Reyes, R. C., Purych, D., Krajden, M., Morshed, M. G., Sekirov, I., Gantt, S. M., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.836449 · Cited by 17
Recent advances in immunoassay technologies for the detection of human coronavirus infections
Wang, D., Chen, Y., Shan, X., Hu, H., Zhan, Y., Yu, Y., Zhang, J., Wu, P., Liu, F. Y., Kai, T., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1040248 · Cited by 16
From conifers to cognition: Microbes, brain and behavior
Lathe, R., & Clair, D. S. (2020) · Genes Brain & Behavior · doi:10.1111/gbb.12680 · Cited by 16
Garritsen, A., Scholzen, A., van den Nieuwenhof, D. W. A., Smits, A. P. F., Datema, E. S., van Galen, L. S., & Kouwijzer, M. (2021) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2021.1893378 · Cited by 15
Mulabbi, E. N., Tweyongyere, R., Wabwire‐Mangen, F., Mworozi, E. A., Koehlerb, J., Kibuuka, H. N., Millard, M., Erima, B., Tugume, T., Ukuli, Q. A., et al. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06258-6 · Cited by 15
Endemic Non–SARS-CoV-2 Human Coronaviruses in a Community-Based Australian Birth Cohort
Grimwood, K., Lambert, S. B., & Ware, R. S. (2020) · PEDIATRICS · doi:10.1542/peds.2020-009316 · Cited by 14
Convalescent Plasma Therapy for Covid-19: State of the ArtPreprint
Focosi, D., Tang, J. W.-T., Anderson, A., & Tuccori, M. (2020) · Preprints.org · doi:10.20944/preprints202004.0097.v7 · Cited by 13
Atypical Antibody Dynamics During Human Coronavirus HKU1 Infections
Sechan, F., Grobben, M., Edridge, A. W. D., Jebbink, M. F., Loens, K., Ieven, M. M., Goossens, H., van Hemert-Glaubitz, S., van Gils, M. J., & van der Hoek, L. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.853410 · Cited by 11
Yin, D., Han, Z., Lang, B., Li, Y., Mai, G., Chen, H., Feng, L., Chen, Y.-Q., Luo, H., Xiong, Y., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1195533 · Cited by 12
Temporal and age distributions of SARS-CoV-2 and other coronaviruses, southeastern France
Colson, P., Esteves-Vieira, V., Giraud‐Gatineau, A., Zandotti, C., Filosa, V., Chaudet, H., Lagier, J., & Raoult, D. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.09.1417 · Cited by 11
Deschermeier, C., Ehmen, C., von Possel, R., Murawski, C., Rushton, B., Amuasi, J., Sarpong, N., Maïga‐Ascofaré, O., Rakotozandrindrainy, R., Asogun, D., et al. (2022) · Journal of Clinical Microbiology · doi:10.1128/jcm.00075-22 · Cited by 10
Frutos, A. M., Kubale, J., Kuan, G., Ojeda, S., Vydiswaran, N., Sánchez, N., Plazaola, M., Patel, M., López, R., Balmaseda, Á., et al. (2022) · PLOS Global Public Health · doi:10.1371/journal.pgph.0000414 · Cited by 10
Denninger, V., Xu, C. K., Meisl, G., Morgunov, A. S., Fiedler, S., Ilsley, A., Emmenegger, M., Malik, A. Y., Piziorska, M. A., Schneider, M. M., et al. (2022) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.1c00486 · Cited by 10
Kolehmainen, P., Heroum, J., Jalkanen, P., Huttunen, M., Toivonen, L., Marjomäki, V., Waris, M. E., Smura, T., Kakkola, L., Tauriainen, S., et al. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.01967-21 · Cited by 12
Analysis of the application value of serum antibody detection for staging of COVID‐19 infection
Zheng, Y., Yan, M., Wang, L., Luan, L., Liu, J., Tian, X. Y., & Wan, N. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26330 · Cited by 9
Li, N., Li, X., Wu, J., Zhang, S., Zhu, L., Chen, Q., Fan, Y., Wu, Z., Xie, S., Chen, Q., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1042406 · Cited by 9
Kolehmainen, P., Huttunen, M., Iakubovskaia, A., Maljanen, S., Tauriainen, S., Yatkin, E., Pasternack, A. H., Naves, R. A., Toivonen, L., Tähtinen, P. A., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-35471-3 · Cited by 12
Dijkstra, J. M., Frenette, A. P., & Dixon, B. (2021) · F1000Research · doi:10.12688/f1000research.51479.1 · Cited by 10
Clinical significance of serum IgM and IgG levels in COVID-19 patients in Hubei Province, China
Bai, Z., Li, Q., Chen, Q., Niu, C., Wei, Y., Huang, H., Zhao, W., Chen, N., Yao, X., Zhang, Q., et al. (2021) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2021.09.001 · Cited by 8
Rees, E. M., Waterlow, N. R., Lowe, R., & Kucharski, A. J. (2021) · Wellcome Open Research · doi:10.12688/wellcomeopenres.16701.1 · Cited by 8
Dowell, A. C., Tut, G., Begum, J., Bruton, R. K., Bentley, C., Butler, M., Uwenedi, G., Zuo, J., Powell, A. A., Brent, A., et al. (2023) · Journal of Infection · doi:10.1016/j.jinf.2023.08.013 · Cited by 9
Epidemiology of endemic human coronavirus infection during the COVID-19 pandemic
Kakuya, F., Terao, R., Onoda, H., Okubo, H., Fujiyasu, H., INYAKU, F., Fukuura, A., Arai, T., & Kinebuchi, T. (2023) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2023.11.012 · Cited by 8
Evaluation of five widely used serologic assays for antibodies to SARS-CoV-2
Stocking, C. J., de Miguel, L., Suteu, G., Dressel, A., Soricelli, A., Roskos, M., Valor, S., Mutschmann, C., & März, W. (2021) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2021.115587 · Cited by 6
Schubl, S. D., Figueroa, C. J., Palma, A. M., de Assis, R. R., Jain, A., Nakajima, R., Jasinskas, A., Brabender, D. E., Hosseinian, S., Naaseh, A., et al. (2023) · BMC Infectious Diseases · doi:10.1186/s12879-023-08284-y · Cited by 6
Convalescent Plasma Therapy for Covid-19: State of the ArtPreprint
Focosi, D., Tang, J. W.-T., Anderson, A. O., & Tuccori, M. (2020) · Preprints.org · doi:10.20944/preprints202004.0097.v5 · Cited by 6
Early seasonal coronavirus seroconversion did not produce cross-protective SARS-CoV-2 antibodies
Wong, L. S. Y., Loo, E. X. L., Huang, C., Yap, G. C., Tay, M. J. Y., Chua, R. X. Y., Kang, A. Y. H., Lu, L., Lee, B. W., Shek, L. P., et al. (2022) · Journal of Infection · doi:10.1016/j.jinf.2022.08.032 · Cited by 6
Frutos, A. M., Balmaseda, Á., Vydiswaran, N., PATEL, M. J., Ojeda, S., Brouwer, A. F., Tutino, R. C., Cai, S., Bakker, K. M., Sánchez, N., et al. (2022) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.13086 · Cited by 5
Erlichster, M., Chana, G., Zantomio, D., Goudey, B., & Skafidas, E. S. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1028 · Cited by 5
Gerges, D., Kapps, S., Hernández-Carralero, E., Freire, R., Aiad, M., Schmidt, S., Winnicki, W., Reiter, T., Pajenda, S., Schmidt, A., et al. (2022) · Viruses · doi:10.3390/v14061181 · Cited by 5
Luo, Y., Lv, H., Zhao, S., Sun, Y., Liu, C.-Y., Chen, C., Liang, W., Kwok, K. O., Teo, Q. W., So, R. T. Y., et al. (2022) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2022.11.044 · Cited by 5
Lobaina, Y., Chen, R., Ai, P., Yang, L.-L., Alvarez‐Lajonchere, L., Suzarte, E., Tan, C., Silva, R., Jiang, Z., Yang, K., et al. (2023) · Viral Immunology · doi:10.1089/vim.2022.0186 · Cited by 4
SARS-CoV-2 Re-infections: Lessons from Other Coronaviruses
van der Hoek, L. (2020) · Med · doi:10.1016/j.medj.2020.12.005 · Cited by 4
Crystal structures of human coronavirus NL63 main protease at different pH values
Gao, H., Zhang, Y., Jiang, H., Hu, X., Zhang, Y., Zhou, X., Zhong, F., Lin, C., Li, J., Luo, J., et al. (2021) · Acta Crystallographica Section F Structural Biology Communications · doi:10.1107/s2053230x21009523 · Cited by 4
Chen, Y., Su, B.-G., Chen, H., Chou, C., & Cheng, H.-C. (2018) · Taiwan Veterinary Journal · doi:10.1142/s1682648518500063 · Cited by 4
Utilizing HCoV-OC43 to better understand the neurological impact of COVID-19
LaCourse, C. (2024) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2024.100905 · Cited by 3
NUEVOS VIRUS RESPIRATORIOS EN PEDIATRÍA
Inostroza, E., & Pinto, R. A. (2017) · Revista Médica Clínica Las Condes · doi:10.1016/j.rmclc.2017.01.005 · Cited by 3
Rees, E. M., Waterlow, N. R., Lowe, R., & Kucharski, A. J. (2021) · Wellcome Open Research · doi:10.12688/wellcomeopenres.16701.3 · Cited by 3
Curtis, N. C., Shin, S., Hederman, A. P., Connor, R. I., Wieland‐Alter, W., Ionov, S., Boylston, J. A., Rose, J., Sakharkar, M., Dorman, D. B., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.08.556349 · Cited by 4
Joseph, J. O., Ylade, M. C., Daag, J. V., Aogo, R. A., Crisostomo, M. V., Mpingabo, P. I., Premkumar, L., Deen, J. L., & Katzelnick, L. C. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-024-09672-8 · Cited by 2
Antibody Responses Against SARS-Cov-2 in COVID-19 and Serological Assays
Çakal, B. (2020) · Turkiye Klinikleri Journal of Health Sciences · doi:10.5336/healthsci.2020-76285 · Cited by 2
Pereira, F. M., de Araujo, A. S., Reis, A. C. M., da Hora, A. S., Pinotti, F., Paton, R. S., Figueiredo, C. V. B., Damasceno, C. L., dos Santos, D. C., de Santana, D. S., et al. (2022) · Viruses · doi:10.3390/v14071549 · Cited by 2
Longitudinal Surveillance of COVID-19 Antibodies in Pediatric Healthcare Workers
Hatabah, D., Gupta, S. L., Mantus, G. E., Sullivan, P. S., Heilman, S. S., Camacho-González, A., Leake, D., Le, U. Q., Griffiths, M., Norwood, C., et al. (2025) · Vaccines · doi:10.3390/vaccines13020163 · Cited by 1
Sayama, Y., Lo, C., Tomizawa, H., Saito, M., Okamoto, M., Ohmiya, S., Nishimura, H., & Oshitani, H. (2024) · IJID Regions · doi:10.1016/j.ijregi.2024.100485 · Cited by 1
Gonzalez‐Lopez, C., Aguilar-Bretones, M., Reinders, J., Zhang, J., van den Doel, P., Bekki, B., Gorp, E. C. M. V., van der Kuy, P. H. M., Haagmans, B. L., GeurtsvanKessel, C. H., et al. (2026) · npj Viruses · doi:10.1038/s44298-026-00185-6 · Cited by 1
Metadata
- Authors
- Zhou, W., Wang, W., Wang, H., Lu, R., & Tan, W.
- Affiliations
- Chinese Center For Disease Control and Prevention (CN)
- Corresponding author
- Tan, Wenjie
- Venue
- BMC Infectious Diseases
- Published
- 2013-09-16
- Volume
- 13
- Issue
- 1
- Pages
- 433-433
- ISSN
- 1471-2334 (ISSN-L)
- PMC
- PMC3848659
- OpenAlex
- W2025196919
- Cited by
- 124
- References
- 35
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 3 · 2023: 15 · 2022: 21 · 2021: 35 · 2020: 32 · 2018: 1 · 2017: 1 · 2016: 3 · 2015: 3 · 2014: 2
- FWCI
- 1.94
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- BMC Infectious Diseases (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Greater South Information System
- Funders
- Peking Union Medical College Hospital
- Peking Union Medical College
- National Key Research and Development Program of China (2011CB504704)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
- Keywords
- human coronaviruses, HCoV-229E, HCoV-HKU1, HCoV-NL63, HCoV-OC43, seroprevalence, seroconversion, pediatric infection, anti-spike IgG, asymptomatic infection, Beijing population
- MeSH terms
- Adolescent, Adult, Aged, Antibodies, Viral, Child, Child, Preschool, Female, Humans, Infant, Male, Middle Aged, Coronavirus, Coronavirus Infections, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
